KYSO Trademark

Trademark Overview


On Tuesday, May 24, 2022, a trademark application was filed for KYSO with the United States Patent and Trademark Office. The USPTO has given the KYSO trademark a serial number of 79344341. The federal status of this trademark filing is REGISTERED as of Tuesday, January 30, 2024. This trademark is owned by Genmab A/S. The KYSO trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Pharmaceutical and veterinary preparations including preparations based on antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof, namely, pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical and veterinary preparations, including preparations based on antibodies, and bi- and multi- specific antibodies as well as fragments, derivatives and conjugates thereof, for the treatment of cancer, autoimmune diseases, and inflammatory disorders

Legal services relating to the exploitation of patents and licensing of intellectual property in the field of medicine

Biological preparations for use in industry and science for in vitro and in vivo scientific and industrial research and development with regard to diseases; biochemical preparations for in vitro and in vivo scientific research purposes with regard to diseases; biochemical reagents used for non-medical purposes in the nature of in vitro and in vivo scientific and industrial research with regard to diseases; chemicals for use in biotechnological product development in the nature of in vitro and in vivo industrial product development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cancer, autoimmune diseases, and inflammatory disorders

Medical, scientific and biological research in the fields of antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof and development of pharmaceutical products based on the same; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data for use in medical scientific research, development and therapy and scientific research, development and therapy with antibodies and bi- and multi- specific antibodies as well as fragments, derivatives or conjugates of any of these
kyso

General Information


Serial Number79344341
Word MarkKYSO
Filing DateTuesday, May 24, 2022
Status700 - REGISTERED
Status DateTuesday, January 30, 2024
Registration Number7292288
Registration DateTuesday, January 30, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2023

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations including preparations based on antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof, namely, pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical and veterinary preparations, including preparations based on antibodies, and bi- and multi- specific antibodies as well as fragments, derivatives and conjugates thereof, for the treatment of cancer, autoimmune diseases, and inflammatory disorders
Goods and ServicesLegal services relating to the exploitation of patents and licensing of intellectual property in the field of medicine
Goods and ServicesBiological preparations for use in industry and science for in vitro and in vivo scientific and industrial research and development with regard to diseases; biochemical preparations for in vitro and in vivo scientific research purposes with regard to diseases; biochemical reagents used for non-medical purposes in the nature of in vitro and in vivo scientific and industrial research with regard to diseases; chemicals for use in biotechnological product development in the nature of in vitro and in vivo industrial product development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cancer, autoimmune diseases, and inflammatory disorders
Goods and ServicesMedical, scientific and biological research in the fields of antibodies, and bi- and multi-specific antibodies as well as fragments, derivatives and conjugates thereof and development of pharmaceutical products based on the same; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data for use in medical scientific research, development and therapy and scientific research, development and therapy with antibodies and bi- and multi- specific antibodies as well as fragments, derivatives or conjugates of any of these

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenmab A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK

Party NameGenmab A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK

Party NameGenmab A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Tuesday, March 14, 2023NON-FINAL ACTION WRITTEN
Thursday, July 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, July 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 12, 2022APPLICATION FILING RECEIPT MAILED
Monday, March 13, 2023ASSIGNED TO EXAMINER
Wednesday, March 15, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 3, 2023REFUSAL PROCESSED BY MPU
Wednesday, May 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 24, 2023REFUSAL PROCESSED BY IB
Friday, September 15, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, October 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 25, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, November 13, 2023NOTIFICATION PROCESSED BY IB
Tuesday, November 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, January 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 15, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, January 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 30, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 30, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 1, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 21, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 1, 2024FINAL DISPOSITION PROCESSED
Monday, January 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED